Christian Niederwieser

Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance)

C. Bloomfield, J. Byrd, K. Mrózek, 2016, Haematologica.

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia

C. Bloomfield, Yue-zhong Wu, K. Metzeler, 2014, Leukemia.

Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response

Judith B. Zaugg, C. Plass, A. Trumpp, 2021, Nature Cancer.

Transplantation in CML in the TKI era: who, when, and how?

N. Kröger, C. Niederwieser, Christian Niederwieser, 2022, Hematology. American Society of Hematology. Education Program.

Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML

N. Kröger, I. Moiseev, B. Afanasyev, 2021, Bone Marrow Transplantation.

COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies

C. Bokemeyer, W. Fiedler, K. Weisel, 2021, Leukemia & lymphoma.

No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group

D. Niederwieser, C. Junghanss, M. Cross, 2020, Leukemia & lymphoma.

Hematopoietic cell transplantation (HCT) in MDS patients of older age

N. Kröger, Christian Niederwieser, 2024, Leukemia & lymphoma.

Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation

N. Steiner, F. Ayuk, C. Wolschke, 2024, Bone marrow transplantation.

Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

N. Kröger, F. Passamonti, F. Ayuk, 2021, Haematologica.